Literature DB >> 2756532

Risk factors for stroke and other embolic events in patients with nonrheumatic atrial fibrillation.

K M Flegel1, J Hanley.   

Abstract

Factors associated with stroke and other cardiac embolic events in subjects with nonrheumatic atrial fibrillation were examined in a retrospective study of 91 patients from a teaching hospital clinic. There were 28 first strokes during 355 person-years of follow-up (7.9 per 100 person-years). Patients who had experienced one or more previous events were approximately 2.3 times more likely to have a subsequent event (hazard ratio 2.3, 95% confidence interval 1.5-3.4) than patients who had experienced no events. A univariate analysis of factors associated with a first stroke of any cause or other embolic event showed that age of greater than 75 years (hazard ratio 2.5) and systolic blood pressure of greater than 160 mm Hg (hazard ratio 6.4) were significant factors. After adjusting for the effect of age and systolic blood pressure, previous events still carried an increased risk for subsequent events. Subject with nonrheumatic atrial fibrillation who have had one or more embolic events are at high risk of further emboli. They require special consideration when treatment is being planned.

Entities:  

Mesh:

Year:  1989        PMID: 2756532     DOI: 10.1161/01.str.20.8.1000

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  Service provision and use of anticoagulants in atrial fibrillation.

Authors:  C M Sudlow; H Rodgers; R A Kenny; R G Thomson
Journal:  BMJ       Date:  1995-08-26

Review 2.  Perioperative stroke. Part II: Cardiac surgery and cardiogenic embolic stroke.

Authors:  D H Wong
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

Review 3.  Age as a Risk Factor for Stroke in Atrial Fibrillation Patients: Implications in Thromboprophylaxis in the Era of Novel Oral Anticoagulants.

Authors:  Konstantina Mitrousi; Gregory Y H Lip; Stavros Apostolakis
Journal:  J Atr Fibrillation       Date:  2013-06-30

Review 4.  Atrial fibrillation pearls and perils of management.

Authors:  P J Kudenchuk
Journal:  West J Med       Date:  1996-05

5.  Ischemic stroke and atrial fibrillation. A clinical study.

Authors:  P Novello; G Ajmar; D Bianchini; G P Bo; S Cammarata; M P Firpo; C I Parodi; A Patrone; N Pizio; M G Poeta
Journal:  Ital J Neurol Sci       Date:  1993-10

6.  Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project)

Authors:  P Sandercock; J Bamford; M Dennis; J Burn; J Slattery; L Jones; S Boonyakarnkul; C Warlow
Journal:  BMJ       Date:  1992-12-12

7.  Low-dose green tea intake reduces incidence of atrial fibrillation in a Chinese population.

Authors:  Dong-Chen Liu; Jian-Jun Yan; You-Nan Wang; Ze-Mu Wang; Zhi-Yong Xie; Yao Ma; Yang Yang; Li Yang; Lian-Sheng Wang
Journal:  Oncotarget       Date:  2016-12-20

8.  Dabigatran exhibits low intensity of left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation as compared with warfarin.

Authors:  Tetsuya Watanabe; Yukinori Shinoda; Kuniyasu Ikeoka; Hirooki Inui; Hidetada Fukuoka; Akihiro Sunaga; Takashi Kanda; Masaaki Uematsu; Shiro Hoshida
Journal:  Heart Vessels       Date:  2016-07-12       Impact factor: 2.037

Review 9.  Atrial Fibrillation in Older People: Concepts and Controversies.

Authors:  Zafraan Zathar; Anne Karunatilleke; Ameenathul M Fawzy; Gregory Y H Lip
Journal:  Front Med (Lausanne)       Date:  2019-08-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.